Clinical Trial Update: Dose Escalation Study of Minnelide in Relapsed or Refractory Acute Myeloid Leukemia [Phase 1]

View source ↗

Summary

Phase 1 dose-escalation study of Minnelide for relapsed or refractory acute myeloid leukemia was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Minnelide (minnelide)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Acute Myeloid Leukemia | Phase 1 | Status: TERMINATED